Exact Mass: 269.178

Exact Mass Matches: 269.178

Found 51 metabolites which its exact mass value is equals to given mass value 269.178, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Orphenadrine

N,N-Dimethyl-2-[(O-methyl-alpha-phenylbenzyl)oxy]ethylamine

C18H23NO (269.178)


Orphenadrine is only found in individuals that have used or taken this drug. It is a muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm. [PubChem]Orphenadrine binds and inhibits both histamine H1 receptors and NMDA receptors. It restores the motor disturbances induced by neuroleptics, in particular the hyperkinesia. The dopamine deficiency in the striatum increases the stimulating effects of the cholinergic system. This stimulation is counteracted by the anticholinergic effect of orphenadrine. It may have a relaxing effect on skeletal muscle spasms and it has a mood elevating effect. D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant CONFIDENCE standard compound; EAWAG_UCHEM_ID 3276

   

Bifemelane

[4-(2-benzylphenoxy)butyl](methyl)amine

C18H23NO (269.178)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants C78272 - Agent Affecting Nervous System

   

N-[(1R)-1-(3-Methoxyphenyl)ethyl]-3-phenylpropan-1-amine

N-[(1R)-1-(3-Methoxyphenyl)ethyl]-3-phenylpropan-1-amine

C18H23NO (269.178)


   

Haplacutine F

Haplacutine F

C18H23NO (269.178)


   

4-MA-NBOMe

4-MA-NBOMe

C18H23NO (269.178)


   

Bifemelane

Bifemelane

C18H23NO (269.178)


D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants C78272 - Agent Affecting Nervous System

   

60783-01-9

60783-01-9

C18H23NO (269.178)


   

(E,E,E)-2-Methylpropylamide-2,4,12-Tetradecatriene-8,10-diynoic acid|12,13-Didehydro-Anacycline|N-isobutyl-2E,4E,12E-tetradecatrien-8,10-diynamide|Tetradeca-2t,4t,12t-trien-8,10-diinsaeure-isobutylamid|tetradeca-2t,4t,12t-triene-8,10-diynoic acid isobutylamide

(E,E,E)-2-Methylpropylamide-2,4,12-Tetradecatriene-8,10-diynoic acid|12,13-Didehydro-Anacycline|N-isobutyl-2E,4E,12E-tetradecatrien-8,10-diynamide|Tetradeca-2t,4t,12t-trien-8,10-diinsaeure-isobutylamid|tetradeca-2t,4t,12t-triene-8,10-diynoic acid isobutylamide

C18H23NO (269.178)


   

deca-3E,6Z,8E-trienoic acid 2-phenylethylamide

deca-3E,6Z,8E-trienoic acid 2-phenylethylamide

C18H23NO (269.178)


   

(E)-3-(3-Hydroxymethyl-2-butenyl)-7-(3-methyl-2-butenyl)-1H-indole

(E)-3-(3-Hydroxymethyl-2-butenyl)-7-(3-methyl-2-butenyl)-1H-indole

C18H23NO (269.178)


   

DTXSID90336249

DTXSID90336249

C18H23NO (269.178)


   

Pyrrolidide-2,4-Tetradecadiene-8,10-diynoic acid|tetradeca-2E,4E-dien-8,10-diynoic acid pyrrolidide

Pyrrolidide-2,4-Tetradecadiene-8,10-diynoic acid|tetradeca-2E,4E-dien-8,10-diynoic acid pyrrolidide

C18H23NO (269.178)


   

3,5-Hexalobine B

3,5-Hexalobine B

C18H23NO (269.178)


   

2-(non-1-en-1-yl)quinolin-4-ol:Series 2 HAQ C9:1

2-(non-1-en-1-yl)quinolin-4-ol:Series 2 HAQ C9:1

C18H23NO (269.178)


   

Norpropoxyphene carbinol

Norpropoxyphene carbinol

C18H23NO (269.178)


   

NA 18:7

N-isobutyl-2E,4E,12E-tetradecatrien-8,10-diynamide

C18H23NO (269.178)


   

Dextrofemine

1-Phenoxy-N-(1-phenyl-2-propanyl)-2-propanamine

C18H23NO (269.178)


   

N,N-dimethyl-2-[(4-methylphenyl)-phenylmethoxy]ethanamine

N,N-dimethyl-2-[(4-methylphenyl)-phenylmethoxy]ethanamine

C18H23NO (269.178)


   

(8r,9s,13s,14s)-3-amino-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one

(8r,9s,13s,14s)-3-amino-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one

C18H23NO (269.178)


   

(R)-(+)-2,3,4,5,6-PENTAFLUOROSTYRENEOXIDE

(R)-(+)-2,3,4,5,6-PENTAFLUOROSTYRENEOXIDE

C18H23NO (269.178)


   

(S)-(-)-2,2-BIS(DI-P-TOLYLPHOSPHINO)-1,1-BINAPHTHYL

(S)-(-)-2,2-BIS(DI-P-TOLYLPHOSPHINO)-1,1-BINAPHTHYL

C18H23NO (269.178)


   

4-phenoxy-2,6-di(propan-2-yl)aniline

4-phenoxy-2,6-di(propan-2-yl)aniline

C18H23NO (269.178)


   

(S)-(-)-2-ACETOXYPROPIONYLCHLORIDE

(S)-(-)-2-ACETOXYPROPIONYLCHLORIDE

C18H23NO (269.178)


   

moxastine

moxastine

C18H23NO (269.178)


C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist

   

Benzenepropanamine, N-(1-(3-methoxyphenyl)ethyl)-

Benzenepropanamine, N-(1-(3-methoxyphenyl)ethyl)-

C18H23NO (269.178)


   

(E)-2-(Non-1-en-1-yl)quinolin-4(1H)-one

(E)-2-(Non-1-en-1-yl)quinolin-4(1H)-one

C18H23NO (269.178)


   

N-(4-ethylphenyl)bicyclo[6.1.0]non-2-ene-9-carboxamide

N-(4-ethylphenyl)bicyclo[6.1.0]non-2-ene-9-carboxamide

C18H23NO (269.178)


   

orphenadrine

orphenadrine

C18H23NO (269.178)


D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065686 - Cytochrome P-450 CYP2B6 Inhibitors D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists D018373 - Peripheral Nervous System Agents > D009465 - Neuromuscular Agents C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

   

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-5-(3-methylbut-2-en-1-yl)-1h-indole

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-5-(3-methylbut-2-en-1-yl)-1h-indole

C18H23NO (269.178)


   

n-(2-phenylethyl)deca-2,6,8-trienimidic acid

n-(2-phenylethyl)deca-2,6,8-trienimidic acid

C18H23NO (269.178)


   

1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8,10-diyn-1-one

1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8,10-diyn-1-one

C18H23NO (269.178)


   

(2e,6z,8e)-n-(2-phenylethyl)deca-2,6,8-trienimidic acid

(2e,6z,8e)-n-(2-phenylethyl)deca-2,6,8-trienimidic acid

C18H23NO (269.178)


   

(2e,4e)-1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8,10-diyn-1-one

(2e,4e)-1-(pyrrolidin-1-yl)tetradeca-2,4-dien-8,10-diyn-1-one

C18H23NO (269.178)


   

2-[(3z)-non-3-en-1-yl]-1h-quinolin-4-one

2-[(3z)-non-3-en-1-yl]-1h-quinolin-4-one

C18H23NO (269.178)


   

(2e,4e,12e)-n-(2-methylpropyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

(2e,4e,12e)-n-(2-methylpropyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

C18H23NO (269.178)


   

(2e)-2-methyl-4-[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]but-2-en-1-ol

(2e)-2-methyl-4-[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]but-2-en-1-ol

C18H23NO (269.178)


   

3-[(3,3-dimethyloxiran-2-yl)methyl]-5-(3-methylbut-2-en-1-yl)-1h-indole

3-[(3,3-dimethyloxiran-2-yl)methyl]-5-(3-methylbut-2-en-1-yl)-1h-indole

C18H23NO (269.178)


   

3-[(3,3-dimethyloxiran-2-yl)methyl]-6-(3-methylbut-2-en-1-yl)-1h-indole

3-[(3,3-dimethyloxiran-2-yl)methyl]-6-(3-methylbut-2-en-1-yl)-1h-indole

C18H23NO (269.178)


   

(2e,4e,12z)-n-(2-methylpropyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

(2e,4e,12z)-n-(2-methylpropyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

C18H23NO (269.178)


   

3-methyl-2-(oct-2-en-1-yl)-1h-quinolin-4-one

3-methyl-2-(oct-2-en-1-yl)-1h-quinolin-4-one

C18H23NO (269.178)


   

n-(2-methylpropyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

n-(2-methylpropyl)tetradeca-2,4,12-trien-8,10-diynimidic acid

C18H23NO (269.178)


   

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-6-(3-methylbut-2-en-1-yl)-1h-indole

3-{[(2r)-3,3-dimethyloxiran-2-yl]methyl}-6-(3-methylbut-2-en-1-yl)-1h-indole

C18H23NO (269.178)


   

3-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-6-(3-methylbut-2-en-1-yl)-1h-indole

3-{[(2s)-3,3-dimethyloxiran-2-yl]methyl}-6-(3-methylbut-2-en-1-yl)-1h-indole

C18H23NO (269.178)


   

n-(2-phenylethyl)deca-2,4,6-trienimidic acid

n-(2-phenylethyl)deca-2,4,6-trienimidic acid

C18H23NO (269.178)


   

3-methyl-2-[(2e)-oct-2-en-1-yl]-1h-quinolin-4-one

3-methyl-2-[(2e)-oct-2-en-1-yl]-1h-quinolin-4-one

C18H23NO (269.178)


   

2-methyl-4-[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]but-2-en-1-ol

2-methyl-4-[7-(3-methylbut-2-en-1-yl)-1h-indol-3-yl]but-2-en-1-ol

C18H23NO (269.178)


   

(2e,4e,6e)-n-(2-phenylethyl)deca-2,4,6-trienimidic acid

(2e,4e,6e)-n-(2-phenylethyl)deca-2,4,6-trienimidic acid

C18H23NO (269.178)


   

(3e,6z,8e)-n-(2-phenylethyl)deca-3,6,8-trienimidic acid

(3e,6z,8e)-n-(2-phenylethyl)deca-3,6,8-trienimidic acid

C18H23NO (269.178)


   

n-(2-phenylethyl)deca-3,6,8-trienimidic acid

n-(2-phenylethyl)deca-3,6,8-trienimidic acid

C18H23NO (269.178)


   

2-[(2e)-non-2-en-1-yl]-1h-quinolin-4-one

2-[(2e)-non-2-en-1-yl]-1h-quinolin-4-one

C18H23NO (269.178)